منابع مشابه
Neuropeptide Y GERALD
NEUROPEPTIDE Y (NPY) was identified as a neuropeptide that is colocalized and coreleased with the neurotransmitter norepinephrine from sympathetic nerve terminals. In this regard, a large body of research on NPY focused on its role in autonomic physiology and pharmacology as a potentiator of the postsynaptic actions of norepinephrine. However, with the increased understanding of the genes and t...
متن کاملIn Focus Neuropeptide Y
NEUROPEPTIDE Y (NPY) was identified as a neuropeptide that is colocalized and coreleased with the neurotransmitter norepinephrine from sympathetic nerve terminals. In this regard, a large body of research on NPY focused on its role in autonomic physiology and pharmacology as a potentiator of the postsynaptic actions of norepinephrine. However, with the increased understanding of the genes and t...
متن کاملNeuropeptide Y: History and Overview
Neuropeptide Y (NPY) is a 36-amino acid peptide with structural similarities to peptide YY (PYY) and pancreatic polypeptide (PP). NPY, one of the most abundant neuropeptides known, is widely distributed throughout the central and peripheral nervous systems, while PYY and PP are predominantly distributed in the endocrine cells of the intestine and pancreas, respectively. Five NPY receptor subtyp...
متن کاملEffects of intracerebral administration of neuropeptide-Y on secretion of luteinizing hormone in ovariectomized sheep.
Ovariectomized ewes received unilateral infusions of 20 micrograms neuropeptide-Y (NPY) at a total of 13 intracerebral sites. Episodic secretion of luteinizing hormone (LH) was transiently suppressed on more than one occasion by daily infusions at a total of five intracerebral sites. Four of the effective sites were located within the third ventricle (two sites) and the rostral and ventral part...
متن کاملNeuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep.
The objective of this study was to determine whether neuropeptide Y (NPY) and recombinant human interleukin-1 receptor antagonist (IL-1ra) would: first, increase food intake; secondly, decrease concentrations of GH; thirdly, reduce GHRH-induced release of GH; and fourthly, reduce changes to concentrations of IGF-I in plasma during experimental endotoxemia in sheep. Six treatments were given to ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: FEBS Letters
سال: 1989
ISSN: 0014-5793
DOI: 10.1016/0014-5793(89)81669-2